Prothena | PRTA - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
Acadia Pharmaceuticals USD 160.79M 14.06M 2026-03
Agios Pharmaceuticals USD 38.46M 4.51M 2026-03
Akebia Therapeutics USD 23.53M 3.19M 2025-12
ALKERMES USD 196.64M 67.96M 2026-06
Alnylam Pharmaceuticals USD 347.92M 65.41M 2026-06
Amgen USD 1.58B 354M 2026-03
Biogen USD 709.7M 155.4M 2026-06
BioMarin Pharmaceutical USD 258.28M 63.92M 2026-03
Exelixis USD 139.6M 16.58M 2026-03
Immunic USD 3.45M 451K 2025-12
Incyte USD 351.73M 23.64M 2026-06
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
MacroGenics USD 9.71M 1.77M 2026-03
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Neurocrine Biosciences USD 383.1M 64.6M 2026-06
Prothena USD 12.67M 5.02M 2026-03
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Ultragenyx Pharmaceutical USD 88M 1000K 2026-03
Vertex Pharmaceuticals USD 493.7M 6.7M 2026-03